Closing in on the truth about recombinant human bone morphogenetic protein-2: Evidence synthesis, data sharing, peer review, and reproducible research

Annals of Internal Medicine

Volumn 158, Issue 12, 2013, Pages 916-918

  Laine, Christine ^a   Guallar, Eliseo ^a   Mulrow, Cynthia ^a   Taichman, Darren B ^a   Cornell, John E ^a   Cotton, Deborah ^a   Griswold, Michael E ^a   Russell Localio, A ^a   Meibohm, Anne R ^a   Stack, Catharine B ^a   Williams, Sankey V ^a   Goodman, Steven N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2;

BONE GRAFT; BONE TRANSPLANTATION; EDITORIAL; HUMAN; PATIENT CARE; PEER REVIEW; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROTEIN SYNTHESIS; QUALITY OF LIFE; RETURN TO WORK; SPINE SURGERY; SURGICAL APPROACH; SYSTEMATIC REVIEW (TOPIC); WELLBEING;

BONE MORPHOGENETIC PROTEIN 2; CONFLICT OF INTEREST; DRUG INDUSTRY; HUMANS; INTERVERTEBRAL DISC DEGENERATION; PUBLICATION BIAS; RECOMBINANT PROTEINS; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84879188276     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-158-12-201306180-00012     Document Type: Editorial

References (12)

1. Simmonds MC, Brown JV, Heirs MK, Higgins JP, Mannion RJ, Rodgers MA, et al. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion. A meta-analysis of individual-participant data. Ann Intern Med. 2013;158:877-89.
2. Fu R, Selph S, McDonagh M, Peterson K, Tiwari A, Chou R, et al. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion. A systematic review and meta-analysis. Ann Intern Med. 2013;158: 890-902.
3. Krumholz HM, Ross JS, Gross CP, Emanuel EJ, Hodshon B, Ritchie JD, et al. A historic moment for open science: the Yale University Open Data Access Project and Medtronic [Editorial]. Ann Intern Med. 2013;158:910-1.
4. Resnick D, Bozic KJ. Meta-analysis of trials of recombinant human bone morphogenetic protein-2: what should spine surgeons and their patients do with this information? [Editorial]. Ann Intern Med. 2013;158:912-3.
5. Kuntz RE. The changing structure of industry-sponsored clinical research: pioneering data sharing and transparency [Editorial]. Ann Intern Med. 2013;158: 914-5.
6. Boden SD, Zdeblick TA, Sandhu HS, Heim SE. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine (Phila Pa 1976). 2000;25:376-81. [PMID: 10703113]
7. Gornet MF, Burkus JK, Dryer RF, Peloza JH. Lumbar disc arthroplasty with Maverick disc versus stand-alone interbody fusion: a prospective, randomized, controlled, multicenter investigational device exemption trial. Spine (Phila Pa 1976).2011;36:E1600-11. [PMID: 21415812]
8. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11:471-91. [PMID: 21729796]
9. Early Breast Cancer Trialists' Collaborative Group. Treatment of Early Breast Cancer Volume 1: Worldwide Evidence 1985-1990. Oxford, UK: Oxford University Pr; 1990.
10. Cohen P. A digital helping hand for scholarly work. The New York Times. 25 June 2011. Accessed at http://query.nytimes.com/gst/fullpage.html?res9A0CE1D61F3EF936A15755C0A9679D8B63&refpatriciacohen on 13 May 2013.
11. Goodman SN, Berlin J, Fletcher SW, Fletcher RH. Manuscript quality before and after peer review and editing at Annals of Internal Medicine. Ann Intern Med. 1994;121:11-21. [PMID: 8198342]
12. Laine C, Goodman SN, Griswold ME, Sox HC. Reproducible research: moving toward research the public can really trust. Ann Intern Med. 2007;146: 450-3. [PMID: 17339612]